Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Anochlesia

5,7-dihydroxytryptamine has been researched along with Anochlesia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopde, CT; Deshpande, LS; Khisti, RT1
Da Prada, M; Haefely, W; Pieri, L; Pieri, M; Schaffner, R1
Cervo, L; Invernizzi, RW; Samanin, R1

Other Studies

3 other study(ies) available for 5,7-dihydroxytryptamine and Anochlesia

ArticleYear
Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
    Brain research, 2001, Apr-13, Volume: 898, Issue:1

    Topics: 5,7-Dihydroxytryptamine; Animals; Bicuculline; Catalepsy; Drug Synergism; Enzyme Inhibitors; GABA Antagonists; Indoleacetic Acids; Indomethacin; Male; Mice; Pregnanolone; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Synaptic Transmission

2001
Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
    Life sciences, 1978, May-08, Volume: 22, Issue:18

    Topics: 5,7-Dihydroxytryptamine; Animals; Apomorphine; Behavior, Animal; Brain Injuries; Catalepsy; Ergolines; Female; Haloperidol; Humans; Hydroxydopamines; Lysergic Acid Diethylamide; Male; Medial Forebrain Bundle; Neural Pathways; Prochlorperazine; Rats; Rotation; Urea

1978
8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.
    Neuropharmacology, 1988, Volume: 27, Issue:5

    Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Catalepsy; Haloperidol; Male; Naphthalenes; Raphe Nuclei; Rats; Receptors, Serotonin; Tetrahydronaphthalenes

1988
chemdatabank.com